Synairgen Share Chat (SNG)

Second one very interesting thanks... sounds like biogen or merck are most likely to be interested in securing the supply of inf beta at least for us market. Sounds like biogen could simply be a supplier and would in that way make the profit, as I cant see governments allowing these companies with life saving treatments to make zillions. The suppliers to the Product though - i think they will make dosh.

Thanks... im thinking if merck are the leading inf beta supplier having merged with schering, then it would make sense for them to buy the access to the patent at least for the usa, or indeed the company but they might not need to buy the company... the multiple pharmas referred to by rm could be eg merck for the us patent, company in china to take control of patent for china, etc etc.

£8 + before the end of the year

And another:
https://www.accessdata.fda.gov/drugsatfda_docs/nda/96/103628Orig1s000rev.pdf

Sparkle, - This isn't the only supplier, but try this:
https://adisinsight.springer.com/drugs/800007022

or was it schering i meant to say before Merck merger? Or is it still biogen or Or or Or ???

replying to Mr Big... my experience says i dont think the big pharma cos will make a ton of profit on this sort of stuff - the governments etc will cut everything to the bone. However, the guys that make the dosh are the downstream suppliers... so if philips makes the neb, who is supplying the INF beta? Does anyone know> as IMHO, they are the guys who will rake it in. Is it Schering? Anyone know?

Geez.. Just in from soiree... Never seen such high value late reporting... Wow..

It was a jest, because breatheasy used the wrong ticker.

i think this is dream land...if we all went out like normal just cos we knew our back was covered, we'd all have massive issue as in short order pretty much the only anti-viral would become pretty useless as (all) viruses would get used to getting round it. Interferon beta will never be taken like aspirin. So if you are eg 30 you can go out on the razzle then give virus to your dad and tell him its ok as he can dose up on what is a pretty strong anti viral drug. This is not going to happen...

who are the suppliers of interferon beta?

No, it's $2.97 at the moment

https://www.google.com/search?client=opera&q=OTCMKTS%3A%23SYGGF&sourceid=opera&ie=UTF-8&oe=UTF-8

T/O for me. I’d be very happy with that. It provides a natural conclusion to the investment and I can move onto other opportunities. There are always other opportunities though none as good as this atm imho.

Completely agree GPS1 that this is priceless, with trillions being printed by governments worldwide to save the economy, this could really be the magic pill to give people and governments the confidence to open up and go back to normal times, because everyone knows there is a super efficient treatment available to now cover your back.

Oils ....never more true words spoken ......savour these moments :-)

ffs guy's... relax, it will come when it's ready.

There are 2 prices that are important here, firstly the share price and Secondly and more importantly is the value of saving lives and that is priceless . These 2 prices will go hand in hand and if this is as good as the trail results indicate then this share could become the once in a decade company to be invested in. I’ve been in this long enough and done enough research to be very confident things will be positive. GLA

Takeover V Partner deal.. What do you think most likely here???

I hope for a T/O.....

And I didn't even mention a desperate US president willing to throw plenty of money at the problem to try to win the November election - which also happens to be when the second wave is coming to the UK and Europe.

They might be analysing them together with some of the home trials.
They might be busy getting reg approvals instead.

Dunno - call RM and ask? Anyone buddies with him?

I hear what you are saying, and I thought you would be saying it. - So other than an NDA, why are we still waiting for COPD findings please?

Scorpio, matt - I imagine big pharmas will take a lion's share of the profits. We hold the IP on the process and will be entitled to some of the profits. We are not going to own the end-to-end process and will not be the only player in the market.
I hope I'm wrong, obviously.

France and The Netherlands have just been added to the quaranteen list
from Saturday...2 weeks...........

COPD wouldn't be part of NDA. NDA will cover the details of negotiations, not the activities of the entire company.

I'm not quite as optimistic as some on here, but as I've said before, I think we're in the middle of a 'perfect' storm (terrible circumstances, of course), but ask yourself how much the Governments around the world have spent propping up economies. £50bn just in the UK.

- No one has an appetite for a second lockdown and this treatment can prevent that.
- This treatment is the 'most promising treatment out there' for COVID and because it is administered by nebuliser it can prevent overwhelming Health Services around the world.
- Vaccines are realistically 12m away (absolute minimum) - and that's assuming everyone wants one.
- Then we've got COPD.

That can't be less than a £3bn company for me., so if the results are as good as the first trial, then we could be looking at a 8 to 9-bagger from here.